Please see additional Important Safety Information for LITFULO on page 3 and full Prescribing Information, including BOXED WARNING, and Medication Guide at LITFULOHCP.com. LITFULO INDICATION LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
REQUIRED MEDICAL INFORMATION: This clinical policy is consistent Litfulo (ritlecitinib) [prescribing information]. New York, NY
Litfulo is a prescription drug used to treat severe alopecia areata in adults and certain children. talk with your doctor or pharmacist or read Litfulo s prescribing information. Mild side
Litfulo (ritlecitinib) [prescribing information]. New York, NY: Pfizer; June 2024. 2. Lee S, et al. Comorbidities in alopecia areata: a
Please see the prescribing guidelines for further information Consider cost. Ritlecitinib (Litfulo ) View adult BNF View SPC online View childrens BNF
LITFULO initiation, see Full Prescribing Information. (2.1). Recommended dosage is 50 mg orally once daily. (2.2). For dosage interruption for certain
LITFULO (ritlecitinib). Profile Picture. LITFULO (ritlecitinib). See Important Safety Info Use below and Full Prescribing Info with BOXED WARNING in the link.
Prior Authorization is recommended for prescription benefit coverage of Litfulo. capsules [prescribing information]. New York, NY: Pfizer;
See full prescribing information for LITFULO. LITFULO (ritlecitinib) capsules, for oral use. Initial U.S. Approval: 2024. WARNING: SERIOUS INFECTIONS
Comments